Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
3.650
+0.610 (20.07%)
At close: Dec 5, 2025, 4:00 PM EST
3.648
-0.002 (-0.04%)
After-hours: Dec 5, 2025, 7:44 PM EST
CDIO Revenue
Cardio Diagnostics Holdings had revenue of $2.86K in the quarter ending September 30, 2025, a decrease of -56.61%. This brings the company's revenue in the last twelve months to $15.78K, down -55.78% year-over-year. In the year 2024, Cardio Diagnostics Holdings had annual revenue of $34.89K with 104.45% growth.
Revenue (ttm)
$15.78K
Revenue Growth
-55.78%
P/S Ratio
422.32
Revenue / Employee
$1,052
Employees
15
Market Cap
6.67M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34.89K | 17.83K | 104.45% |
| Dec 31, 2023 | 17.07K | 16.12K | 1,696.32% |
| Dec 31, 2022 | 950.00 | 49.00 | 5.44% |
| Dec 31, 2021 | 901.00 | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CDIO News
- 3 days ago - Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) - Business Wire
- 4 weeks ago - Cardio Diagnostics Holdings, Inc. to Present Data Demonstrating PrecisionCHD's Ability to Detect INOCA and MINOCA at the American Heart Association Scientific Sessions - Business Wire
- 5 weeks ago - Cardio Diagnostics Holdings, Inc. and YMCA of East Tennessee Partner to Bring Heart Health Education and Advanced Testing to East Tennessee Community - Business Wire
- 6 weeks ago - Cardio Diagnostics Holdings, Inc. Expands Provider Network, Adding 15 New Provider Organizations From Across the United States - Business Wire
- 4 months ago - Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) - Business Wire
- 5 months ago - Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease - Business Wire
- 6 months ago - Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology - Business Wire
- 6 months ago - Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price - Business Wire